Lung Cancer Breakout: Breakthrough treatments for longer life

As the most common cancer worldwide, lung cancer impacts approximately 2.1 million people each year. Hope for millions is on the horizon as the lung cancer death rate in the United States has dropped dramatically over the last few years with the introduction of new treatments, including immunotherapy. Immunotherapy for lung cancer, alone or in combination with conventional treatments, can significantly improve outcomes for lung cancer patients. Join medical oncologist Dr. Julie Brahmer, of Johns Hopkins Medicine, to hear about several recently approved immunotherapy options and ask your questions about how immunotherapy is advancing the treatment of lung cancer. We’ll discuss PD-L1 expression, treatment response, length of treatment, clinical trials, and more.

[@Alpha_7227]

Hi I am currently having Nivolumab every fortnight in Melbourne Australia. This medication was just approved to treat patients after having chemo/radiotherapy and an esophagectomy. It has its side effects but I am handling it alright although I am taking time off work as the fatigue, diarhoea, itchiness and breathlessness can take its toll. Keep up the fantastic work.

[@rishab1231000]

How are you right now

[@elizabethparker3456]

Hopefully iam benefits for this treatment

[@josphatlombe]

How do I get access to pdl1 treatment. Iam from zambia. Immunotherapy form

[@wallypaige8496]

This doesn't help if you have scaring, right. My lung cancer has grown, so I don't know how long I got

[@FedoSirl]

Ayo thats very precise

[@Michael43056]

what if my lung cancer came from my lymph system which got infected from a skin cancer, squamous cell? Do I still have a chance to beat this or is it just a matter of time?

[@jokjones1]

I'm in the same position as you except it's bcc. Good luck and best wishes.